Maviret Filmtabletten

7680664720013 CH-66472 Filmtabletten
Maviret Filmtabletten
Maviret Filmtabletten
Maviret Filmtabletten
1 / 3
google

Article details

Package size
84
Selling units
84
Measure
Tablette(n)
Galenic form
Filmtabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
15/09/2026
Patient information leaflet
Français
15/09/2026
Patient information leaflet
Italien
15/09/2026
Summary of Product Characteristics
Allemand
15/09/2026
Summary of Product Characteristics
Français
15/09/2026
Summary of Product Characteristics
Italien
15/09/2026

Detailed composition

Substance Quantity Type Category
glecaprevirum
100.0 MG Substance Wirkstoff (Principe actif)
pibrentasvirum
40.0 MG Substance Wirkstoff (Principe actif)
copovidonum K 28
- Substance HNIDK
tocofersolanum
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
propylenglycoli monocaprylas
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
natrii stearylis fumaras
- Substance HNIDK
hypromellosum
- Substance HNIDK
lactosum monohydricum
7.87 MG Substance HBESI
macrogolum 3350
- Substance HNIDK
E 171
- Substance FNIDK
E 172 (rubrum)
- Substance FTODK
natrium
2.6 MG Substance HBESI

Reimbursement information

Public price
CHF 13798.25
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/12/2017

Authorization holder

AbbVie AG

6330 Cham

Authorization information

Swissmedic authorization number
66472
Drug name
Maviret, Filmtabletten
Galenic form
FILM
ATC Code
J05AP57
Authorization status
Z
Dispensing category
A
First authorization
22/09/2017
Authorization expiration date
31/12/9999
IT Number
08.03.0.
Domain
Human medicine
Field of application
Chronische Hepatitis C

Package details

Description (FR)
MAVIRET comprimés pelliculés 100mg/40mg 84 pce
Description (DE)
MAVIRET Filmtabletten 100mg/40mg 84 Stk
Market launch
22/09/2017
Narcotic (BTM)
No
Buy us a coffee Explore the data